Corcept Therapeutics Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2014
Total Assets: $34.6M
Liabilities Breakdown FY2014
Total Liabilities: $38.0M
Asset Breakdown
Total Assets: $34.6M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $24.2M | 70.0% |
| Accounts Receivable | $3.3M | 9.6% |
| Inventory | $1.2M | 3.5% |
| Property, Plant & Equipment | $236.0K | 0.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $5.6M | 16.2% |
Liabilities Breakdown
Total Liabilities: $38.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.9M | 5.0% |
| Long-Term Debt | $24.5M | 64.3% |
| Other Liabilities | $11.7M | 30.7% |